Royal Bank of Canada
PRVL

Royal Bank of Canada’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Royal Bank of Canada’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$27K Buy
2020
Q3 		$9K Sell
2020
Q2 		$14K Sell
2020
Q1 		$12K Sell
2019
Q4 		$23K Buy